Serial 86715524
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 16 Jul 2022)
What this means for you
Registered since 06 Dec 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86715524
- Registration number
- 5096597
- Mark type
- Design / logo
- Filed
- 05 Aug 2015
- Published for opposition
- 16 Feb 2016
- Registered
- 06 Dec 2016
- Attorney of record
- Jennifer Sheehan Anderson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of chronic liver diseases
Owner
- INTERCEPT PHARMACEUTICALS, INC., NEW YORK, NY, US
- INTERCEPT PHARMACEUTICALS, INC., NEW YORK, NY, US
- RXF Technologies, Inc., Royal Oak, MI, US
- RXF Technologies, Inc., Royal Oak, MI, US
Prosecution history
- 06 Dec 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 16 Jul 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Jul 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 Jul 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Feb 2022 — TEAS SECTION 8 & 15 RECEIVED
- 06 Dec 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Sept 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Dec 2016 — REGISTERED-PRINCIPAL REGISTER
- 02 Nov 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Nov 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Oct 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Oct 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Oct 2016 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 24 Oct 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE